2,246 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Purchased by West Bancorporation Inc.

West Bancorporation Inc. bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the third quarter, according to its most recent Form 13F filing with the SEC. The firm bought 2,246 shares of the company’s stock, valued at approximately $211,000.

A number of other large investors have also made changes to their positions in the stock. Wellington Management Group LLP grew its holdings in shares of GE HealthCare Technologies by 575.6% in the fourth quarter. Wellington Management Group LLP now owns 21,118 shares of the company’s stock valued at $1,633,000 after purchasing an additional 17,992 shares during the period. Park Avenue Securities LLC purchased a new stake in shares of GE HealthCare Technologies in the 1st quarter valued at approximately $227,000. Wealthcare Advisory Partners LLC acquired a new stake in shares of GE HealthCare Technologies during the 1st quarter worth approximately $255,000. Independence Bank of Kentucky raised its position in shares of GE HealthCare Technologies by 89.7% during the 1st quarter. Independence Bank of Kentucky now owns 924 shares of the company’s stock valued at $84,000 after buying an additional 437 shares during the period. Finally, Annapolis Financial Services LLC lifted its holdings in GE HealthCare Technologies by 171.9% in the first quarter. Annapolis Financial Services LLC now owns 348 shares of the company’s stock valued at $32,000 after acquiring an additional 220 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 0.5 %

NASDAQ:GEHC traded down $0.48 during trading hours on Friday, hitting $88.42. The company’s stock had a trading volume of 2,035,620 shares, compared to its average volume of 2,909,492. The stock has a fifty day moving average of $88.42 and a 200-day moving average of $83.43. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.55. The stock has a market capitalization of $40.38 billion, a P/E ratio of 25.70, a price-to-earnings-growth ratio of 3.34 and a beta of 1.18. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping the consensus estimate of $0.98 by $0.02. The company had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The business’s revenue was up .5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.92 EPS. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.49%.

Insider Activity at GE HealthCare Technologies

In other news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the transaction, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.27% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Stifel Nicolaus lifted their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research report on Monday, September 30th. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their target price for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. Evercore ISI lifted their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective on the stock. Finally, BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a report on Wednesday, September 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $94.23.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.